Tianjin Chase Sun Pharmaceutical Co.,Ltd announced earnings results for the nine months ended September 30, 2019. For the nine months, the company announced sales was CNY 3,602.061 million compared to CNY 3,029.742 million a year ago. Operating income was CNY 620.473 million compared to CNY 549.795 million a year ago. Net income was CNY 516.260 million compared to CNY 463.232 million a year ago. Basic earnings per share from continuing operations was CNY 0.17 compared to CNY 0.15 a year ago.